Recruiting
The Florida ASCENT Study
NCT07042243
- Conditions
- Behavior, Behavior, Animal, Breast Cancer, +56 more
- Locations
-
- University of Florida Gainesville, Florida, United States
Clinical trial condition
Urogenital Neoplasms
Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.
11,815 public trials
2,511 recruiting studies
Urogenital Neoplasms trial results
NCT07524322
- Conditions
- Adnexal Diseases, Advanced Breast Cancer, Breast Cancer, +30 more
- Locations
-
- START Los Angeles Los Angeles, California, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- NEXT Houston Houston, Texas, United States
- NEXT San Antonio San Antonio, Texas, United States
NCT03564340
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
- Locations
-
- University of Alabama_6th Ave Birmingham, Alabama, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States
- Mayo Clinic - Rochester Rochester, Minnesota, United States
NCT05438563
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT07216456
- Conditions
- Anorectal Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
- Conditions
- Androgen Axis Suppression, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Banner MD Anderson Gilbert, Arizona, United States
- Rush MD Anderson Chicago, Illinois, United States
- University of Kansas Medical Center Kansas City, Kansas, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT06770582
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
- Locations
-
- Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
- Highlands Oncology Group - Rogers Rogers, Arkansas, United States
- Highlands Oncology Group Springdale, Arkansas, United States
- AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
NCT07306559
- Conditions
- Adnexal Diseases, Advanced Relapsed or Refractory Endometrial Cancer, Advanced Relapsed or Refractory Germ Cell Tumours, +18 more
- Locations
-
- Valkyrie Clinical Trials Los Angeles, California, United States
- Indiana University Indianapolis, Indiana, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Cliniques Universitaires Saint-Luc Brussels, Belgium
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
NCT04879329
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
- Locations
-
- Banner Gateway Medical Center Gilbert, Arizona, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Kaiser Permanente Anaheim Kraemer Medical Offices Anaheim, California, United States
- Foothill Cardioology Arcadia, California, United States
NCT07720284
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
- Locations
-
- Research Site Hot Springs, Arkansas, United States
- Research Site Little Rock, Arkansas, United States
- Research Site Little Rock, Arkansas, United States
- Research Site San Francisco, California, United States